Internetové knihkupectví s veterinární tématikou
Publikace je praktickou a ilustrovaná příručkou s podrobným popisem cytologických rysů jaterních onemocnění a četnými vysoce kvalitními ilustracemi, které pomohou čtenáři lépe pochopit problematiku onemocnění jater. Primárním cílem textu je popsat korelaci cytologických nálezů s patologickými procesy s cílem poskytnout klinickým lékařům užitečné informace v léčbě jaterních onemocnění.
Publikace obsahuje informace o:
Obecných východiscích pro interpretaci jaterní cytologie, s uvedením limitů cytologie.
Významu cytologie jater pro definitivní diagnózu a vztah ke klinickým výsledkům.
Specifických reverzibilních poškozeních hepatocytů zahrnující hepatocelulární edém, steroidy indukovanou hepatopatii, hepatocelulární steatózu a degeneraci jater.
Nevratném poškození hepatocytů, zahrnující nekrózu, apoptózu, zánět jater, neutrofilní, eozinofilní, makrofagický a lymfoplasmacytický zánět.
Intra a extracytoplazmatických patologických akumulacích zahrnující lipofuscin, měď, železo, eozinofilní granule, proteinové kapénky, žluč a amyloid.
Chronických onemocněních jater se zaměřením na cytologické znaky fibrózy.
Nemocích žlučových cest a žlučníku.
Neoplastických onemocněních pokrývající epiteliální, mezenchymální a kulatobuněčné nádory.
Publikace umožňuje čtenářům interpretovat všechny cytopatologické změny jater se vztahem ke klinickým primárním a sekundárním příčinám, případně s histopatologickou diagnózou, Publikaci je vysoce ceněna jako významný zdroj informací pro veterinární lékaře a studenty.
Autor: Carlo Masserdotti
Nakladatel | Wiley-Blackwell |
---|---|
ISBN | 9781119895541 |
Vydání | 2024 |
Vazba | pevná |
Počet stran | 288 |
Specialist reference with practical guidance on liver pathology in a clinical and anatomical context
Canine and Feline Liver Cytology is a practical and highly illustrated manual with detailed descriptions of cytological features of hepatic diseases and numerous high-quality illustrations to aid in reader comprehension. The primary aim of the text is to describe the correlation of cytological findings with pathological processes in order to provide useful information to clinicians in management of hepatic diseases.
Canine and Feline Liver Cytology includes information on:
General bases for interpretation of hepatic cytology, covering limits of cytology, value of cytology for a definitive diagnosis, and relationship with clinical data
A specific reversible injury to hepatocytes, covering hepatocellular swelling, steroid induced hepatopathy, hepatocellular steatosis, and feathery degeneration
Irreversible injury to hepatocytes, covering necrosis and apoptosis, and inflammation, covering neutrophilic, eosinophilic, macrophagic, and lymphoplasmacytic inflammation
Intra and extracytoplasmic pathologic accumulation, covering lipofuscin, copper, iron, eosinophilic granules, protein droplet, bile, and amyloid
Chronic hepatic diseases, with focus on cytological features of fibrosis
Diseases of biliary tract and gallbladder
Neoplastic diseases, covering epithelial, mesenchymal and round cell tumors
Canine and Feline Liver Cytology enables readers to interpret all the cytopathological changes in liver pathology and the relationship with clinical primary and secondary causes, eventually with histopathological diagnosis, making it a highly valuable resource for veterinary practitioners and students.
ABOUT THE AUTHOR
Carlo Masserdotti, DVM, Dipl ECVCP, Spec Bioch Clin IAT, Consultant, Anatomic and Clinical Pathology, IDEXX Laboratories, Brescia, Italy.
About the Author | ix |
Foreword | xi |
Preface | xiii |
Acknowledgments | xv |
1 Before the Analysis: Rules for Interpretation of Hepatic Cytology | 1 |
1.1 The Rules for Cytological Diagnosis of Hepatic Diseases | 2 |
1.1.1 Rule 1 | 2 |
1.1.3 Rule 3 | 2 |
1.1.4 Rule 4 | 3 |
1.1.5 Rule 5 | 3 |
1.1.6 Rule 6 | 3 |
1.1.7 Rule 7 | 4 |
1.1.8 Rule 8 | 4 |
1.2 Diagnostic Approach to Liver Disease | 4 |
1.2.1 Clinical and Anamnestic Signs | 5 |
1.2.2 Hematochemical Investigation | 5 |
1.2.2.1 Pathological Bases of Liver Damage | 5 |
1.2.2.2 Diagnosis of Liver Damage | 8 |
1.2.2.3 Useful Enzymes for Recognition of Damage to Hepatocytes and Cholangiocytes | 9 |
1.2.2.4 Liver Failure Diagnosis | 11 |
1.2.2.5 Parameters of Liver Failure | 12 |
1.2.3 Ultrasonographic Investigation | 14 |
1.2.4 Cytological and Histopathological Investigation | 15 |
1.2.4.1 Sample Collection | 15 |
1.2.4.2 Cytological Approach to Hepatic Diseases | 16 |
1.3 Key Points | 16 |
References | 17 |
2 Normal Histology and Cytology of the Liver | 19 |
2.1 Normal Histology of the Liver | 19 |
2.2 Normal Cytology of the Liver | 27 |
2.2.1 Hepatocytes | 28 |
2.2.2 Kupffer Cells | 30 |
2.2.3 Stellate Cells (Ito Cells) | 31 |
2.2.4 Cholangiocytes (Biliary Cells) | 32 |
2.2.5 Hepatic Lymphocytes | 33 |
2.2.6 Hepatic Mast Cells | 34 |
2.2.7 Hematopoietic Cells | 34 |
2.2.8 Mesothelial Cells | 36 |
2.3 Key Points | 38 |
References | 39 |
3 Nonspecific and Reversible Hepatocellular Damage | 41 |
3.1 Accumulation of Water | 42 |
3.2 Accumulation of Glycogen | 43 |
3.3 Accumulation of Lipids | 46 |
3.4 Accumulation of Bilirubin and Bile Salts | 57 |
3.5 Hyperplasia of Stellate Cells | 57 |
3.6 Regenerative Changes | 59 |
3.7 Key Points | 64 |
References | 64 |
4 Intracytoplasmic and Extracytoplasmic Pathological Accumulation | 67 |
4.1 Pathological Intracytoplasmic Accumulation | 67 |
4.1.1 Lipofuscin | 67 |
4.1.2 Copper | 73 |
4.1.3 Iron and Hemosiderin | 76 |
4.1.4 Protein Droplets | 82 |
4.1.5 Cytoplasmic Granular Eosinophilic Material | 82 |
4.1.6 Hepatic Lysosomal Storage Disorders | 85 |
4.2 Pathological Extracytoplasmic Accumulation | 86 |
4.2.1 Bile | 86 |
4.2.2 Amyloid | 90 |
4.3 Key Points | 96 |
References | 96 |
5 Irreversible Hepatocellular Damage | 101 |
5.1 Necrosis | 101 |
5.2 Apoptosis | 107 |
5.3 Key Points | 110 |
References | 110 |
6 Inflammation | 113 |
6.1 Presence of Neutrophilic Granulocytes | 115 |
6.2 Presence of Eosinophilic Granulocytes | 123 |
6.3 Presence of Lymphocytes and Plasma Cells | 125 |
6.4 Presence of Macrophages | 130 |
6.5 Presence of Mast Cells | 137 |
6.6 Key Points | 139 |
References | 139 |
7 Nuclear Inclusions | 143 |
7.1 “Brick” Inclusions | 143 |
7.2 Glycogen Pseudo-inclusions | 144 |
7.3 Lead Inclusions | 146 |
7.4 Viral Inclusions | 146 |
7.5 Key Points | 147 |
References | 147 |
8 Cytological Features of Liver Fibrosis | 149 |
8.1 Cytological Features of Liver Fibrosis | 150 |
8.2 Key Points | 159 |
References | 160 |
9 Cytological Features of Biliary Diseases | 163 |
9.1 General Features of Biliary Diseases | 165 |
9.2 Cytological Features of Specific Biliary Diseases | 167 |
9.2.1 Acute and Chronic Cholestasis | 167 |
9.2.2 Acute Cholangitis | 170 |
9.2.3 Chronic Cholangitis | 170 |
9.2.4 Lymphocytic Cholangitis | 170 |
9.3 Key Points | 175 |
References | 175 |
10 Bile and Gallbladder Diseases | 177 |
10.1 Bactibilia and Septic Cholecystitis | 179 |
10.2 Epithelial Hyperplasia | 181 |
10.3 Gallbladder Mucocele | 181 |
10.4 Limy Bile Syndrome | 183 |
10.5 Biliary Sludge | 183 |
10.6 Neoplastic Diseases of Gallbladder | 183 |
10.7 Other Gallbladder Diseases | 184 |
10.8 Key Points | 184 |
References | 184 |
11 Etiological Agents | 187 |
11.1 Viruses | 188 |
11.2 Bacteria | 189 |
11.3 Protozoa | 193 |
11.4 Fungi | 194 |
11.5 Parasites | 194 |
11.6 Key Points | 197 |
References | 197 |
12 Neoplastic Lesions of the Hepatic Parenchyma | 199 |
12.1 Epithelial Neoplasia | 200 |
12.1.1 Nodular Hyperplasia | 200 |
12.1.2 Hepatocellular Adenoma | 204 |
12.1.3 Hepatocellular Carcinoma | 206 |
12.1.4 Cholangioma | 215 |
12.1.5 Cholangiocellular Carcinoma | 217 |
12.1.6 Other Nodular Lesions of Biliary Origin | 222 |
12.1.7 Hepatic Carcinoid | 223 |
12.1.8 Hepatoblastoma | 227 |
12.2 Mesenchymal Neoplasia | 227 |
12.2.1 Malignant Mesenchymal Neoplasms | 227 |
12.3 Hematopoietic Neoplasia | 229 |
12.3.1 Myelolipoma | 231 |
12.3.2 Large Cell Hepatic Lymphoma | 232 |
12.3.3 Small Cell Lymphoma | 234 |
12.3.4 Large Granular Lymphocyte (LGL) Lymphoma | 236 |
12.3.5 Epitheliotropic Lymphoma | 239 |
12.3.6 Other Types of Hepatic Lymphoma | 240 |
12.3.7 Malignant Histiocytic Neoplasms | 242 |
12.3.8 Mast Cell Tumor | 245 |
12.3.9 Hepatic Splenosis | 247 |
12.4 Metastatic Neoplasia | 247 |
12.5 Criteria for Selection of Sampling Methods for Liver Nodular Lesions | 248 |
12.6 Key Points | 250 |
References | 250 |
Index | 255 |